Checkpoint Inhibitor Pneumonitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-23
Clinical Trial Update: Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis [Phase 2]
A Phase 2 clinical trial sponsored by AHS Cancer Control Alberta is recruiting to test inhaled budesonide for recurrence prevention and as a…